Complete Filing Data
Monte Rosa Therapeutics, Inc. reported Stockholders Equity of $233.06 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Monte Rosa Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$38.6M | -$72.7M | -$135.4M | -$108.5M | -$74.0M | -$35.9M |
| Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax | -$519.0K | -$802.0K | -$1.4M | $718.0K | -$965.0K | -$1.1M |
| Research And Development Expense | $141.5M | $121.6M | $111.3M | $85.1M | $57.2M | $24.0M |
| Operating Income Loss | -$54.2M | -$81.1M | -$143.3M | -$112.4M | -$72.9M | -$28.0M |
| Operating Expenses | $177.9M | $156.7M | $143.3M | $112.4M | $72.9M | $28.0M |
| Nonoperating Income Expense | $14.5M | $11.0M | $8.3M | $3.9M | -$1.1M | -$7.9M |
| Interest Income Expense Nonoperating Net | $12.9M | $10.6M | $9.3M | $3.8M | $46.0K | $9.0K |
| General And Administrative Expense | $36.4M | $35.2M | $32.0M | $27.3M | $15.7M | $4.0M |
| Comprehensive Income Net Of Tax | -$39.1M | -$73.3M | -$136.3M | -$108.2M | -$74.9M | -$36.9M |
| Income Loss From Continuing Operations Per Diluted Share | -$0.46 | -$0.98 | -$2.63 | -$2.30 | -$2.96 | |
| Income Loss From Continuing Operations Per Basic Share | -$0.46 | -$0.98 | -$2.63 | -$2.30 | -$2.96 | |
| Income Tax Expense Benefit | -$1.1M | $2.6M | $338.0K | $0.00 | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$39.7M | -$70.1M | -$135.0M | -$108.5M | ||
| Revenue From Contract With Customer Including Assessed Tax | $123.7M | $75.6M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$27.1M | -$12.3M | $46.9M | -$23.9M | -$30.3M | -$32.0M | -$34.9M | -$35.2M | -$32.0M | -$27.3M | -$26.5M | -$23.9M | -$19.8M | -$18.4M | -$12.3M | -$6.6M | -$5.4M | -$4.3M |
| Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax | $53.0K | $53.0K | $48.0K | $37.0K | $35.0K | $35.0K | $14.0K | $14.0K | $14.0K | $32.0K | $33.0K | $34.0K | -$535.0K | -$495.0K | $136.0K | |||
| Research And Development Expense | $36.7M | $30.7M | $32.2M | $27.6M | $28.1M | $27.0M | $28.3M | $29.1M | $26.8M | $21.3M | $20.9M | $17.9M | $15.1M | $14.6M | $9.3M | $5.5M | $4.9M | |
| Operating Income Loss | -$33.0M | -$15.6M | $44.0M | -$26.5M | -$32.6M | -$34.9M | -$37.0M | -$37.2M | -$34.3M | -$28.4M | -$27.2M | -$24.3M | -$19.9M | -$18.1M | -$11.5M | -$6.4M | -$5.4M | |
| Operating Expenses | $45.7M | $38.7M | $40.9M | $35.7M | $37.3M | $36.0M | $37.0M | $37.2M | $34.3M | $28.4M | $27.2M | $24.3M | $19.9M | $18.1M | $11.5M | $6.4M | $5.4M | |
| Nonoperating Income Expense | $2.7M | $4.5M | $3.7M | $2.7M | $2.6M | $3.1M | $2.3M | $2.2M | $2.2M | $1.0M | $762.0K | $370.0K | $31.0K | -$282.0K | -$772.0K | -$172.0K | $32.0K | |
| Interest Income Expense Nonoperating Net | $2.7M | $3.1M | $3.4M | $2.9M | $2.6M | $2.4M | $2.2M | $2.3M | $2.4M | $997.0K | $628.0K | $149.0K | $13.0K | $14.0K | $6.0K | $2.0K | $1.0K | |
| General And Administrative Expense | $9.1M | $8.1M | $8.7M | $8.1M | $9.3M | $9.0M | $8.7M | $8.1M | $7.5M | $7.0M | $6.3M | $6.4M | $4.8M | $3.5M | $2.2M | $914.0K | $541.0K | |
| Comprehensive Income Net Of Tax | -$27.0M | -$12.3M | $46.9M | -$23.5M | -$30.3M | -$31.9M | -$34.7M | -$35.4M | -$31.7M | -$27.5M | -$26.8M | -$24.0M | -$20.4M | -$18.9M | -$12.1M | -$6.6M | -$5.4M | |
| Income Loss From Continuing Operations Per Diluted Share | -$0.33 | -$0.15 | $0.57 | -$0.29 | -$0.43 | -$0.53 | -$0.70 | -$0.71 | -$0.65 | -$0.58 | -$0.57 | -$0.51 | -$0.43 | -$3.63 | ||||
| Income Loss From Continuing Operations Per Basic Share | -$0.33 | -$0.15 | $0.57 | -$0.29 | -$0.43 | -$0.53 | -$0.70 | -$0.71 | -$0.65 | -$0.58 | -$0.57 | -$0.51 | -$0.43 | -$3.63 | ||||
| Income Tax Expense Benefit | -$3.2M | $1.2M | $822.0K | $71.0K | $252.0K | $83.0K | $170.0K | $190.0K | $0.00 | $0.00 | $0.00 | |||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$30.3M | -$11.1M | $47.7M | -$23.8M | -$30.1M | -$31.9M | -$34.7M | -$35.0M | -$32.0M | -$27.3M | -$26.5M | |||||||
| Revenue From Contract With Customer Including Assessed Tax | $12.8M | $23.2M | $84.9M | $9.2M | $4.7M | $1.1M | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $233.1M | $222.9M | $179.3M | $271.4M | $347.5M | -$48.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $134.8M | $229.1M | $132.7M | $60.2M | $351.4M | $42.9M | $9.2M |
| Cash And Cash Equivalents At Carrying Value | $129.9M | $224.3M | $128.1M | $54.9M | $346.1M | $41.7M | |
| Gain Loss On Disposition Of Assets1 | $59.0K | $0.00 | $24.0K | $109.0K | $0.00 | ||
| Available For Sale Debt Securities Gross Unrealized Loss | $170.0K | $397.0K | $449.0K | ||||
| Property Plant And Equipment Net | $26.0M | $29.5M | $33.8M | $27.1M | $12.3M | $4.6M | |
| Retained Earnings Accumulated Deficit | -$477.2M | -$438.6M | -$365.9M | -$230.5M | -$122.0M | -$48.1M | |
| Restricted Cash Noncurrent | $5.0M | $4.9M | $4.6M | $4.3M | $5.3M | $1.2M | |
| Restricted Cash | $5.0M | $4.9M | $4.6M | $5.3M | $5.3M | $1.2M | |
| Prepaid Expense And Other Assets Current | $4.5M | $5.1M | $3.3M | $4.4M | $2.6M | $1.9M | |
| Liabilities Current | $64.2M | $156.9M | $46.6M | $25.6M | $16.6M | $29.3M | |
| Liabilities And Stockholders Equity | $448.7M | $438.7M | $303.8M | $342.4M | $366.3M | $49.4M | |
| Liabilities | $215.6M | $215.8M | $124.5M | $71.0M | $18.8M | $30.3M | |
| Defined Benefit Pension Plan Liabilities Noncurrent | $5.3M | $3.7M | $2.7M | $1.5M | $2.2M | $1.1M | |
| Debt Securities Available For Sale Realized Loss | -$47.0K | -$170.0K | -$397.0K | $449.0K | $0.00 | ||
| Common Stock Value | $7.0K | $6.0K | $5.0K | $5.0K | $5.0K | $1.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$94.3M | $96.4M | $72.5M | -$291.2M | $308.5M | $33.6M | |
| Assets Current | $393.2M | $377.4M | $236.2M | $275.9M | $348.7M | $43.6M | |
| Assets | $448.7M | $438.7M | $303.8M | $342.4M | $366.3M | $49.4M | |
| Additional Paid In Capital Common Stock | $714.1M | $664.9M | $547.9M | $503.7M | $471.6M | $404.0K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$3.8M | -$3.4M | -$2.7M | -$1.8M | -$2.0M | -$1.1M | |
| Accounts Payable Current | $3.6M | $17.2M | $11.2M | $7.9M | $6.6M | $7.1M | |
| Accounts Payable And Other Accrued Liabilities Current | $26.7M | $18.8M | $14.6M | $14.6M | $10.1M | $2.5M | |
| Gain Loss On Sale Of Property Plant Equipment | $59.0K | $0.00 | $24.0K | $109.0K | -$17.0K | $0.00 | |
| Operating Lease Liability Noncurrent | $34.8M | $39.0M | $42.9M | $43.9M | $0.00 | ||
| Marketable Securities | $247.2M | $147.9M | $104.3M | $207.9M | $0.00 | ||
| Accretion Of Discounts Premiums On Marketable Securities Net | -$2.1M | -$2.9M | -$3.9M | -$1.9M | $0.00 | ||
| Other Assets Noncurrent | $148.0K | $115.0K | $352.0K | $278.0K | $0.00 | ||
| Operating Lease Right Of Use Asset | $24.4M | $26.8M | $28.8M | $34.8M | $0.00 | ||
| Operating Lease Liability Current | $4.4M | $3.7M | $3.2M | $3.1M | $0.00 | ||
| Other Receivables | $4.6M | $173.0K | $505.0K | $7.7M | $0.00 | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Changes In Fair Value Of Preferred Stock Tranche Obligations Net | $0.00 | -$960.0K | -$7.7M | ||||
| Reduction Of Right Of Use Assets For Lease Incentives Receivable | $0.00 | $5.3M | $7.5M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $245.8M | $268.1M | $275.2M | $205.5M | $224.7M | $152.5M | $184.5M | $213.7M | $243.7M | $291.1M | $302.1M | $325.9M | $369.3M | $356.7M | -$60.6M | -$28.2M | -$21.7M | -$16.4M | -$12.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $213.3M | $74.4M | $83.4M | $130.5M | $113.7M | $104.6M | $63.6M | $51.6M | $57.1M | $117.7M | $109.0M | $143.6M | $368.8M | $358.8M | $169.6M | $52.6M | $12.7M | ||
| Cash And Cash Equivalents At Carrying Value | $208.3M | $69.4M | $78.5M | $125.6M | $108.8M | $99.8M | $59.1M | $47.0M | $51.8M | $112.4M | $103.7M | $138.3M | $367.0M | $357.1M | $168.4M | $51.7M | $12.7M | ||
| Gain Loss On Disposition Of Assets1 | $0.00 | $0.00 | $59.0K | $0.00 | $0.00 | $0.00 | $0.00 | $24.0K | $0.00 | -$16.0K | $0.00 | $125.0K | $0.00 | $0.00 | |||||
| Available For Sale Debt Securities Gross Unrealized Loss | $97.0K | $21.0K | $311.0K | $12.0K | $4.0K | $171.0K | $261.0K | $345.0K | $176.0K | $358.0K | $146.0K | ||||||||
| Property Plant And Equipment Net | $27.6M | $29.1M | $29.3M | $31.4M | $33.3M | $34.0M | $35.0M | $35.3M | $33.8M | $19.4M | $15.2M | $13.4M | $11.8M | $8.9M | |||||
| Retained Earnings Accumulated Deficit | -$431.1M | -$404.0M | -$391.7M | -$452.0M | -$428.2M | -$397.9M | -$332.6M | -$297.8M | -$262.6M | -$199.8M | -$172.4M | -$146.0M | -$98.6M | -$78.8M | |||||
| Restricted Cash Noncurrent | $5.0M | $5.0M | $4.9M | $4.9M | $4.9M | $4.9M | $4.5M | $4.5M | $4.3M | $4.3M | $5.3M | $5.3M | $1.7M | $1.7M | |||||
| Restricted Cash | $5.0M | $5.0M | $4.9M | $4.9M | $4.9M | $4.9M | $4.5M | $4.5M | $5.3M | $5.3M | $5.3M | $5.3M | $1.7M | $1.7M | $1.2M | $960.0K | $0.00 | ||
| Prepaid Expense And Other Assets Current | $5.6M | $6.5M | $4.8M | $8.4M | $5.8M | $5.5M | $4.1M | $3.9M | $5.7M | $4.6M | $2.9M | $3.2M | $3.5M | $1.2M | |||||
| Liabilities Current | $61.4M | $41.9M | $59.2M | $41.6M | $42.3M | $41.3M | $22.6M | $19.1M | $20.5M | $21.8M | $14.8M | $12.5M | $12.7M | $10.8M | |||||
| Liabilities And Stockholders Equity | $459.8M | $359.6M | $393.2M | $315.1M | $344.1M | $266.7M | $252.1M | $278.6M | $309.0M | $357.6M | $365.1M | $346.0M | $384.0M | $368.9M | |||||
| Liabilities | $214.0M | $91.5M | $118.0M | $109.6M | $119.4M | $114.2M | $67.6M | $65.0M | $65.3M | $66.5M | $63.0M | $20.1M | $14.7M | $12.3M | |||||
| Defined Benefit Pension Plan Liabilities Noncurrent | $4.7M | $4.6M | $4.0M | $2.8M | $2.6M | $2.6M | $1.5M | $1.5M | $1.5M | $2.1M | $2.1M | $2.2M | $2.0M | $1.5M | |||||
| Debt Securities Available For Sale Realized Loss | $21.0K | -$311.0K | $12.0K | $4.0K | -$171.0K | $261.0K | -$345.0K | $176.0K | $358.0K | $146.0K | $0.00 | $0.00 | |||||||
| Common Stock Value | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$145.7M | -$28.1M | -$3.1M | -$207.8M | $126.7M | ||||||||||||||
| Assets Current | $401.8M | $299.5M | $332.3M | $251.2M | $277.9M | $199.0M | $182.9M | $208.1M | $240.6M | $295.2M | $297.0M | $320.4M | $370.5M | $358.3M | |||||
| Assets | $459.8M | $359.6M | $393.2M | $315.1M | $344.1M | $266.7M | $252.1M | $278.6M | $309.0M | $357.6M | $365.1M | $346.0M | $384.0M | $368.9M | |||||
| Additional Paid In Capital Common Stock | $680.2M | $675.4M | $670.2M | $659.8M | $655.5M | $553.1M | $518.6M | $513.0M | $507.7M | $493.4M | $476.9M | $474.0M | $469.8M | $436.8M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$3.2M | -$3.4M | -$3.3M | -$2.3M | -$2.7M | -$2.7M | -$1.5M | -$1.6M | -$1.4M | -$2.6M | -$2.5M | -$2.1M | -$2.0M | -$1.4M | |||||
| Accounts Payable Current | $14.5M | $5.6M | $6.5M | $4.0M | $6.5M | $6.8M | $5.5M | $5.3M | $7.4M | $9.8M | $4.3M | $4.5M | $3.5M | $7.5M | |||||
| Accounts Payable And Other Accrued Liabilities Current | $17.9M | $13.8M | $16.3M | $15.1M | $12.8M | $10.7M | $14.2M | $11.1M | $10.2M | $9.0M | $7.8M | $6.5M | $9.2M | $3.3M | |||||
| Gain Loss On Sale Of Property Plant Equipment | $59.0K | $0.00 | $0.00 | $125.0K | $0.00 | ||||||||||||||
| Operating Lease Liability Noncurrent | $35.9M | $37.0M | $38.0M | $40.1M | $40.9M | $41.8M | $43.5M | $44.4M | $43.3M | $42.6M | $46.1M | $5.5M | |||||||
| Marketable Securities | $182.9M | $221.2M | $247.5M | $116.6M | $153.4M | $93.1M | $119.4M | $156.0M | $179.9M | $159.8M | $190.5M | $178.9M | |||||||
| Accretion Of Discounts Premiums On Marketable Securities Net | -$1.0M | -$69.0K | -$1.3M | -$45.0K | $0.00 | ||||||||||||||
| Other Assets Noncurrent | $411.0K | $445.0K | $440.0K | $159.0K | $209.0K | $389.0K | $270.0K | $291.0K | $351.0K | $148.0K | $384.0K | ||||||||
| Operating Lease Right Of Use Asset | $25.1M | $25.7M | $26.3M | $27.4M | $27.9M | $28.4M | $29.4M | $30.4M | $30.5M | $38.5M | $47.1M | ||||||||
| Operating Lease Liability Current | $4.2M | $4.1M | $3.9M | $3.6M | $3.5M | $3.3M | $2.9M | $2.7M | $2.9M | $3.1M | $2.7M | ||||||||
| Other Receivables | $5.0M | $2.4M | $1.4M | $595.0K | $842.0K | $601.0K | $294.0K | $1.2M | $2.2M | $4.1M | |||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Changes In Fair Value Of Preferred Stock Tranche Obligations Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$960.0K | $0.00 | $0.00 | |||||||||||
| Reduction Of Right Of Use Assets For Lease Incentives Receivable | $0.00 | $3.4M | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $18.9M | $18.1M | $16.7M | $11.7M | $5.2M | $354.0K |
| Proceeds From Stock Options Exercised | $5.7M | $1.1M | $2.0M | $439.0K | $149.0K | $0.00 |
| Payments To Acquire Property Plant And Equipment | $4.7M | $4.0M | $19.0M | $12.9M | $9.7M | $3.4M |
| Net Cash Provided By Used In Operating Activities | -$22.8M | $42.0M | -$43.8M | -$92.5M | -$59.4M | -$23.1M |
| Net Cash Provided By Used In Investing Activities | -$101.8M | -$44.5M | $88.8M | -$219.2M | -$9.7M | -$3.4M |
| Net Cash Provided By Used In Financing Activities | $30.4M | $98.9M | $27.5M | $20.5M | $377.6M | $60.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$604.0K | $1.6M | -$1.1M | $2.1M | $704.0K | $1.4M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $7.9M | $4.2M | $3.6M | $1.0M | $6.6M | $1.1M |
| Increase Decrease In Accounts Payable | -$13.7M | $6.3M | $5.8M | -$744.0K | -$706.0K | $3.4M |
| Payments To Acquire Marketable Securities | $376.7M | $230.4M | $103.2M | $384.4M | $0.00 | |
| Increase Decrease In Operating Lease Liability | -$1.1M | -$1.3M | $10.4M | -$181.0K | $0.00 | |
| Increase Decrease In Other Receivables | $4.4M | -$332.0K | -$1.9M | $187.0K | $0.00 | |
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $62.0K | $109.0K | $79.0K | ||
| Payments Of Stock Issuance Costs | $290.0K | $116.0K | $984.0K | $231.0K | $440.0K | |
| Proceeds From Sale And Maturity Of Marketable Securities | $0.00 | $45.6M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q2 2024 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $5.3M | $4.9M | $4.0M | $2.3M | $252.0K | |
| Proceeds From Stock Options Exercised | $14.0K | $246.0K | $18.0K | $153.0K | $0.00 | |
| Payments To Acquire Property Plant And Equipment | $1.6M | $1.4M | $9.2M | $1.7M | $2.2M | |
| Net Cash Provided By Used In Operating Activities | -$45.5M | -$38.2M | -$23.4M | -$27.4M | -$13.8M | |
| Net Cash Provided By Used In Investing Activities | -$100.2M | $9.9M | $20.3M | -$180.5M | -$2.2M | |
| Net Cash Provided By Used In Financing Activities | $14.0K | $246.0K | $18.0K | $153.0K | $142.8M | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $4.0K | $2.3M | -$1.3M | $608.0K | $1.4M | |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$2.6M | -$3.9M | -$3.3M | -$3.6M | -$738.0K | |
| Increase Decrease In Accounts Payable | -$10.9M | -$5.1M | $306.0K | -$2.2M | -$906.0K | |
| Payments To Acquire Marketable Securities | $138.0M | $56.1M | $67.8M | $179.0M | $0.00 | |
| Increase Decrease In Operating Lease Liability | -$283.0K | -$471.0K | $6.9M | -$375.0K | $0.00 | |
| Increase Decrease In Other Receivables | $1.2M | $10.0K | -$2.1M | $0.00 | ||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $125.0K | $0.00 | |||
| Payments Of Stock Issuance Costs | $290.0K | $0.00 | $231.0K | |||
| Proceeds From Sale And Maturity Of Marketable Securities | $0.00 | $45.6M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 83.1M | 73.9M | 51.4M | 47.2M | 25.0M | |
| Weighted Average Number Of Diluted Shares Outstanding | 83.1M | 73.9M | 51.4M | 47.2M | 25.0M | |
| Common Stock Shares Outstanding | 65.5M | 61.5M | 50.1M | 49.3M | 46.5M | 1.7M |
| Common Stock Shares Issued | 65.5M | 61.5M | 50.2M | 49.4M | 46.8M | 2.2M |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 97.5M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Earnings Per Share Basic And Diluted | $-2.96 | $-23.65 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 82.4M | 82.2M | 82.1M | 82.0M | 71.2M | 60.2M | 49.8M | 49.4M | 49.3M | 46.7M | 46.7M | 46.6M | 46.0M | 5.1M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 82.4M | 82.2M | 83.0M | 82.0M | 71.2M | 60.2M | 49.8M | 49.4M | 49.3M | 46.7M | 46.7M | 46.6M | 46.0M | 5.1M | |||
| Common Stock Shares Outstanding | 61.8M | 61.7M | 61.5M | 61.4M | 61.3M | 50.2M | 50.1M | 49.6M | 49.4M | 48.4M | 46.7M | 46.6M | 46.5M | 44.6M | |||
| Common Stock Shares Issued | 61.8M | 61.7M | 61.5M | 61.4M | 61.3M | 50.2M | 50.1M | 49.6M | 49.5M | 48.5M | 46.9M | 46.9M | 46.8M | 45.0M | |||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Earnings Per Share Basic And Diluted | $0.51 | $-0.43 | $-3.63 | $7.18 | $-4.29 | $-3.64 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $18.9M | $18.1M | $16.7M | $11.7M | $5.2M | $354.0K |
| Provision For Pension Benefit Obligation | -$518.0K | -$802.0K | -$1.4M | $718.0K | -$965.0K | -$1.1M |
| Foreign Currency Transaction Gain Loss Before Tax | $1.5M | $416.0K | -$930.0K | $10.0K | -$162.0K | -$198.0K |
| Depreciation | $8.4M | $8.1M | $6.2M | $3.7M | $2.1M | $537.0K |
| Stock Issued During Period Value Stock Options Exercised | $5.7M | $1.1M | $2.0M | $439.0K | $148.0K | |
| Capital Expenditures Incurred But Not Yet Paid | $149.0K | $50.0K | $237.0K | $6.2M | $656.0K | $458.0K |
| Defined Benefit Plan Other Changes | -$1.0M | -$187.0K | $188.0K | -$74.0K | -$1.1M | -$1.1M |
| Proceedsfrommaturityofmarketablesecurities | $279.5M | $189.9M | $165.3M | $178.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.4M | $4.9M | $5.3M | $4.3M | $4.5M | $4.9M | $4.5M | $4.2M | $4.0M | $3.2M | $2.9M | $2.3M | $2.1M | $1.0M | $252.0K | $45.0K | $97.0K | $11.0K |
| Provision For Pension Benefit Obligation | $53.0K | $53.0K | $48.0K | $37.0K | $35.0K | $35.0K | $14.0K | $14.0K | $14.0K | $32.0K | $33.0K | $34.0K | -$535.0K | -$495.0K | $136.0K | $0.00 | $0.00 | |
| Foreign Currency Transaction Gain Loss Before Tax | -$29.0K | $1.4M | $173.0K | -$153.0K | -$53.0K | $620.0K | $27.0K | -$93.0K | -$85.0K | $63.0K | $134.0K | $96.0K | $18.0K | -$296.0K | $182.0K | -$174.0K | $31.0K | |
| Depreciation | $2.1M | $2.1M | $2.0M | $2.1M | $2.1M | $1.9M | $1.8M | $1.4M | $1.2M | $1.0M | $889.0K | $753.0K | $600.0K | $400.0K | $274.0K | |||
| Stock Issued During Period Value Stock Options Exercised | $348.0K | $14.0K | $15.0K | $422.0K | $246.0K | $1.1M | $897.0K | $18.0K | $79.0K | $96.0K | $153.0K | $128.0K | ||||||
| Capital Expenditures Incurred But Not Yet Paid | $304.0K | $983.0K | $4.4M | $794.0K | $1.2M | |||||||||||||
| Defined Benefit Plan Other Changes | -$307.0K | $110.0K | $7.0K | -$41.0K | $0.00 | |||||||||||||
| Proceedsfrommaturityofmarketablesecurities | $39.4M | $67.3M | $51.7M | $0.00 |
Most recent annual filing with the SEC: March 17, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.